[144] Akamai Technologies Inc SEC Filing

Rhea-AI Filing Summary

Akamai Technologies, Inc. (AKAM) Form 144 shows a proposed insider sale of 4,000 common shares via Charles Schwab & Co., with an aggregate market value of $303,040. The filing lists total outstanding shares of 143,385,528 and an approximate sale date of 08/20/2025. The 4,000 shares were acquired through equity compensation: 2,476 shares from a performance stock lapse on 02/19/2025 and 1,524 shares from a restricted stock lapse on 03/06/2025. No sales in the past three months are reported and the filer certifies no undisclosed material adverse information.

Insights

Insider Transactions Analyst

TL;DR: Small executive sale notice for 4,000 shares from recent equity vesting; immaterial to overall capitalization.

The Form 144 documents a proposed sale tied to recent equity compensation vesting events totaling 4,000 shares valued at $303,040. Relative to the 143.4 million shares outstanding, the sale size is negligible and appears to be routine monetization of vested equity rather than liquidation of a large stake. The filing reports no prior sales in the past three months, which suggests this is a discrete transaction rather than an ongoing selling program. Impact on share supply and market liquidity is likely minimal.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 and contains required acquisition/payment details; no governance red flags disclosed.

The notice provides the necessary Rule 144 details: acquisition dates, nature of acquisition (performance stock lapse and restricted stock lapse), broker information, and a certification regarding material nonpublic information. There is no indication of a 10b5-1 plan adoption date in the remarks. From a governance perspective, the form meets regulatory disclosure standards and does not reveal material governance concerns or undisclosed related-party transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4000	303040.00	143385528	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2025	Performance Stock Lapse	Akamai Technologies, Inc.			2476	02/19/2025	Equity Compensation
Common	03/06/2025	Restricted Stock Lapse	Akamai Technologies, Inc.			1524	03/06/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many AKAM shares does the Form 144 propose to sell?

The filing proposes the sale of 4,000 common shares.

What is the aggregate market value of the shares to be sold in the AKAM Form 144?

The aggregate market value listed is $303,040.

When were the shares acquired that are listed for sale (AKAM)?

Shares were acquired by equity compensation: 2,476 on 02/19/2025 (performance stock lapse) and 1,524 on 03/06/2025 (restricted stock lapse).

Through which broker will the AKAM shares be sold?

The broker listed is Charles Schwab & Co., Inc. located at 3000 Schwab Way, Westlake, TX 76262.

What is the approximate date of sale stated in the AKAM Form 144?

The approximate date of sale is 08/20/2025.

Does the filing report any securities sold by the person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.